Sara F. Kost

Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells.

ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells.

Journal: Blood advances

Published: July 31, 2024

Venetoclax inhibits autophagy in chronic lymphocytic leukemia cells.

Venetoclax inhibits autophagy in chronic lymphocytic leukemia cells.

Journal: Autophagy reports

Published: February 07, 2023

DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease.

DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease.

Journal: Blood cancer journal

Published: August 16, 2022

Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines.

Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines.

Journal: Leukemia research

Published: January 11, 2021

Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia.

Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia.

Journal: Cancers

Published: August 12, 2019

Buccal cell telomere length is not a useful marker for comorbidities in chronic lymphocytic leukemia.

Buccal cell telomere length is not a useful marker for comorbidities in chronic lymphocytic leukemia.

Journal: Leukemia research

Published: July 04, 2019

A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia.

A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia.

Journal: Leukemia research

Published: March 07, 2017

Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia.

Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia.

Journal: Leukemia research

Published: March 18, 2016

Transcriptome atlas of the Arabidopsis funiculus--a study of maternal seed subregions.

Transcriptome atlas of the Arabidopsis funiculus--a study of maternal seed subregions.

Journal: The Plant journal : for cell and molecular biology

Published: November 26, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026